Vis AN - Search Results

1

Pathologic features of prostate cancer found at population-based screening with a four-year interval.

Hoedemaeker RF, van der Kwast TH, Boer R, de Koning HJ, Roobol M, Vis AN, Schröder FH. Hoedemaeker RF, et al. Among authors: vis an. J Natl Cancer Inst. 2001 Aug 1;93(15):1153-8. doi: 10.1093/jnci/93.15.1153. J Natl Cancer Inst. 2001. PMID: 11481387 Free article. Clinical Trial.

2

Prostate cancer detection at low prostate specific antigen.

Schröder FH, van der Cruijsen-Koeter I, de Koning HJ, Vis AN, Hoedemaeker RF, Kranse R. Schröder FH, et al. Among authors: vis an. J Urol. 2000 Mar;163(3):806-12. J Urol. 2000. PMID: 10687982 Clinical Trial.

3

Quantitative analysis of the decay of immunoreactivity in stored prostate needle biopsy sections.

Vis AN, Kranse R, Nigg AL, van der Kwast TH. Vis AN, et al. Am J Clin Pathol. 2000 Mar;113(3):369-73. doi: 10.1309/CQWY-E3F6-9KDN-YV36. Am J Clin Pathol. 2000. PMID: 10705817

4

Detection of prostate cancer: a comparative study of the diagnostic efficacy of sextant transrectal versus sextant transperineal biopsy.

Vis AN, Boerma MO, Ciatto S, Hoedemaeker RF, Schröder FH, van der Kwast TH. Vis AN, et al. Urology. 2000 Oct 1;56(4):617-21. doi: 10.1016/s0090-4295(00)00681-6. Urology. 2000. PMID: 11018617

5

Prognostic value of cell cycle proteins p27(kip1) and MIB-1, and the cell adhesion protein CD44s in surgically treated patients with prostate cancer.

Vis AN, Noordzij MA, Fitoz K, Wildhagen MF, Schröder FH, van der Kwast TH. Vis AN, et al. J Urol. 2000 Dec;164(6):2156-61. J Urol. 2000. PMID: 11061947

6

Staging prostate cancer.

Hoedemaeker RF, Vis AN, Van Der Kwast TH. Hoedemaeker RF, et al. Among authors: vis an. Microsc Res Tech. 2000 Dec 1;51(5):423-9. doi: 10.1002/1097-0029(20001201)51:5<423::AID-JEMT4>3.0.CO;2-4. Microsc Res Tech. 2000. PMID: 11074612 Review.

7

Molecular cytogenetic analysis of prostatic adenocarcinomas from screening studies : early cancers may contain aggressive genetic features.

Alers JC, Krijtenburg PJ, Vis AN, Hoedemaeker RF, Wildhagen MF, Hop WC, van Der Kwast TT, Schröder FH, Tanke HJ, van Dekken H. Alers JC, et al. Among authors: vis an. Am J Pathol. 2001 Feb;158(2):399-406. doi: 10.1016/s0002-9440(10)63983-1. Am J Pathol. 2001. PMID: 11159178 Free PMC article.

8

Prostate-specific antigen-based early detection of prostate cancer--validation of screening without rectal examination.

Schröder FH, Roobol-Bouts M, Vis AN, van der Kwast T, Kranse R. Schröder FH, et al. Among authors: vis an. Urology. 2001 Jan;57(1):83-90. doi: 10.1016/s0090-4295(00)00863-3. Urology. 2001. PMID: 11164149 Clinical Trial.

9

Defining the window of opportunity in screening for prostate cancer: validation of a predictive tumor classification model.

Vis AN, Hoedemaeker RF, van der Kwast TH, Schröder FH. Vis AN, et al. Prostate. 2001 Feb 1;46(2):154-62. doi: 10.1002/1097-0045(20010201)46:2<154::aid-pros1019>3.0.co;2-1. Prostate. 2001. PMID: 11170143 Clinical Trial.

10

Tumor characteristics in screening for prostate cancer with and without rectal examination as an initial screening test at low PSA (0.0-3.9 ng/ml).

Vis AN, Hoedemaeker RF, Roobol M, van der Kwast TH, Schröder FH. Vis AN, et al. Prostate. 2001 Jun 1;47(4):252-61. doi: 10.1002/pros.1069. Prostate. 2001. PMID: 11398172 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

173 results

Search Page

Filters